In bone-marrow-derived human mesenchymal stem cells under inflammatory state (MSC-TI) CCL5 expression was upregulated and increased expression of CCR1, CCR3 and CCR5 was found in CCA cells treated with MSC-TI conditioned medium [147]. This evidence concerns the gene CCL5 and cholangiocarcinoma.